At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
An Open-Label, Randomized Study to Evaluate the Relative Bioavailability of a New Tablet Formulation of Minzasolmin and the Potential Effect of Food on the Pharmacokinetics of Minzasolmin in Healthy Participants
In Brief
A Phase 1 clinical trial evaluating Minzasolmin tablet formulation under fasting condition, Minzasolmin Granules in capsule under fasting condition, and 1 other intervention for Healthy Participants. Completed, enrolled 18 participants across 1 site.
Detailed Summary
The purpose of the study is to estimate the relative bioavailability of a new minzasolmin tablet formulation versus reference 'granules in capsule' formulation in healthy participants and to evaluate the effect of food with the new tablet formulation on the pharmacokinetics (PK) of minzasolmin.
Study Details
Timeline
Interventions
Drug: Minzasolmin Pharmaceutical form: Tablet formulation under fasting condition
Drug: Minzasolmin Pharmaceutical form: Granules in capsule under fasting condition
Drug: Minzasolmin Pharmaceutical form: Tablet formulation under fed condition